BioMarin Yahoo Finance / Mar 19, 2021
Want to see the real deal?
More inside scoop? View in App
More inside scoop? View in App
FOLLOWING
Show more
BioMarin News
BioMarin MarketBeat / Mar 19, 2021
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Jeffrey Robert Ajer sold 1,308 shares of the firm's stock in a transaction that occurred on Thursday, March 18th. The shares were sold at an average price of $77.99, for a total value of $102,010.92.
MarketBeat
BioMarin KSU | The Sentinel Newspaper / Mar 19, 2021
The Phenylketonuria Treatment Market is expected to grow at a CAGR of 8.6% and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020. The factors leading to this extraordinary growth is attributed various market dynamics discussed in the report Our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions.
KSU | The Sentinel Newspaper
BioMarin KSU | The Sentinel Newspaper / Mar 19, 2021
Summary on Global Friedreich Ataxia Drug Market 2021-2026: A recent research report on the Global Friedreich Ataxia Drug Market presents a complete overview and comprehensive explanation of the industry. It is an analytical study focuses on target groups of customers covering historical, current, and future market revenue and growth rate for both demand and supply side.
BioMarin KSU | The Sentinel Newspaper / Mar 19, 2021
The Rare Disease Treatment Market is expected to grow at a CAGR of 7.4% and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020. The factors leading to this extraordinary growth is attributed various market dynamics discussed in the report Our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions.
BioMarin KSU | The Sentinel Newspaper / Mar 19, 2021
Making accurate business decisions is always a tough task. However, if the company has acquired proper insights about the market, making those decisions becomes easy. Industry Growth Insights (IGI) offers the right support any business requires in the form of its meticulous research reports.
BioMarin KSU | The Sentinel Newspaper / Mar 19, 2021
The newly added research report by Industry Growth Insights (IGI) on the Global Phenylketonuria Treatment Market is a detailed guide to understand several factors that play a vital role in growth progression. The report is fabricated in such a way that fosters the investment decisions and motivates crucial investment discretion for new businesses looking out for seamless market penetration.
BioMarin NeighborWebSJ / Mar 19, 2021
The report titled Global Hemophilia A Drug Market is one of the most comprehensive and important additions to QY Research's archive of market research studies. It offers detailed research and analysis of key aspects of the global Hemophilia A Drug market.
BioMarin KSU | The Sentinel Newspaper / Mar 19, 2021
Industry Growth Insights (IGI) has recently published a comprehensive report entitled Global Phenylketonuria (PKU) Market focusing to offer a complete overview of the market. This report provides a latest updated information regarding various crucial aspects of the market, which are expected to have a major impact on the market trend and performance during the forecast period.
BioMarin Cabell Standard / Mar 19, 2021
